Hydroxychloroquine attenuates renal ischemia/reperfusion injury by inhibiting cathepsin mediated NLRP3 inflammasome activation

Inflammation is a major contributor to the pathogenesis of ischemic acute kidney injury (AKI), which complicates the post-operative outcomes of large numbers of hospitalized surgical patients. Hydroxychloroquine (HCQ), a well-known anti-malarial drug, is commonly used in clinical practice for its an...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Cell death & disease Ročník 9; číslo 3; s. 351 - 14
Hlavní autori: Tang, Tao-Tao, Lv, Lin-Li, Pan, Ming-Ming, Wen, Yi, Wang, Bin, Li, Zuo-Lin, Wu, Min, Wang, Feng-Mei, Crowley, Steve D, Liu, Bi-Cheng
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: London Nature Publishing Group UK 02.03.2018
Springer Nature B.V
Predmet:
ISSN:2041-4889, 2041-4889
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Abstract Inflammation is a major contributor to the pathogenesis of ischemic acute kidney injury (AKI), which complicates the post-operative outcomes of large numbers of hospitalized surgical patients. Hydroxychloroquine (HCQ), a well-known anti-malarial drug, is commonly used in clinical practice for its anti-inflammatory actions. However, little is known about its role in renal ischemia/reperfusion (I/R) injury. In the current study, mice were subjected to I/R injury and HCQ was administered for seven days by gavage prior to surgery. In parallel, HK-2 human renal proximal tubule cells were prophylactically treated with HCQ and then were exposed to hypoxia/reoxygenation (H/R). The results showed that HCQ significantly attenuated renal dysfunction evidenced by blunted decreases in serum creatinine and kidney injury molecular-1 expression and the improvement of HK-2 cell viability. Additionally, HCQ markedly reduced macrophage and neutrophil infiltration, pro-inflammatory cytokine production, and NLRP3 inflammasome activation. Mechanistic studies showed that HCQ could inhibit the priming of the NLRP3 inflammasome by down-regulating I/R or H/R-induced NF-κB signaling. Moreover, HCQ reduced cathepsin (CTS) B, CTSD and CTSL activity, and their redistribution from lysosomes to cytoplasm. CTSB and CTSL (not CTSD) were implicated in I/R triggered NLRP3 inflammasome activation. Notably, we found that HCQ attenuated renal injury through downregulation of CTSB and CTSL-mediated NLRP3 inflammasome activation. This study provides new insights into the anti-inflammatory effect of HCQ in the treatment of AKI.
AbstractList Inflammation is a major contributor to the pathogenesis of ischemic acute kidney injury (AKI), which complicates the post-operative outcomes of large numbers of hospitalized surgical patients. Hydroxychloroquine (HCQ), a well-known anti-malarial drug, is commonly used in clinical practice for its anti-inflammatory actions. However, little is known about its role in renal ischemia/reperfusion (I/R) injury. In the current study, mice were subjected to I/R injury and HCQ was administered for seven days by gavage prior to surgery. In parallel, HK-2 human renal proximal tubule cells were prophylactically treated with HCQ and then were exposed to hypoxia/reoxygenation (H/R). The results showed that HCQ significantly attenuated renal dysfunction evidenced by blunted decreases in serum creatinine and kidney injury molecular-1 expression and the improvement of HK-2 cell viability. Additionally, HCQ markedly reduced macrophage and neutrophil infiltration, pro-inflammatory cytokine production, and NLRP3 inflammasome activation. Mechanistic studies showed that HCQ could inhibit the priming of the NLRP3 inflammasome by down-regulating I/R or H/R-induced NF-κB signaling. Moreover, HCQ reduced cathepsin (CTS) B, CTSD and CTSL activity, and their redistribution from lysosomes to cytoplasm. CTSB and CTSL (not CTSD) were implicated in I/R triggered NLRP3 inflammasome activation. Notably, we found that HCQ attenuated renal injury through downregulation of CTSB and CTSL-mediated NLRP3 inflammasome activation. This study provides new insights into the anti-inflammatory effect of HCQ in the treatment of AKI.
Inflammation is a major contributor to the pathogenesis of ischemic acute kidney injury (AKI), which complicates the post-operative outcomes of large numbers of hospitalized surgical patients. Hydroxychloroquine (HCQ), a well-known anti-malarial drug, is commonly used in clinical practice for its anti-inflammatory actions. However, little is known about its role in renal ischemia/reperfusion (I/R) injury. In the current study, mice were subjected to I/R injury and HCQ was administered for seven days by gavage prior to surgery. In parallel, HK-2 human renal proximal tubule cells were prophylactically treated with HCQ and then were exposed to hypoxia/reoxygenation (H/R). The results showed that HCQ significantly attenuated renal dysfunction evidenced by blunted decreases in serum creatinine and kidney injury molecular-1 expression and the improvement of HK-2 cell viability. Additionally, HCQ markedly reduced macrophage and neutrophil infiltration, pro-inflammatory cytokine production, and NLRP3 inflammasome activation. Mechanistic studies showed that HCQ could inhibit the priming of the NLRP3 inflammasome by down-regulating I/R or H/R-induced NF-κB signaling. Moreover, HCQ reduced cathepsin (CTS) B, CTSD and CTSL activity, and their redistribution from lysosomes to cytoplasm. CTSB and CTSL (not CTSD) were implicated in I/R triggered NLRP3 inflammasome activation. Notably, we found that HCQ attenuated renal injury through downregulation of CTSB and CTSL-mediated NLRP3 inflammasome activation. This study provides new insights into the anti-inflammatory effect of HCQ in the treatment of AKI.Inflammation is a major contributor to the pathogenesis of ischemic acute kidney injury (AKI), which complicates the post-operative outcomes of large numbers of hospitalized surgical patients. Hydroxychloroquine (HCQ), a well-known anti-malarial drug, is commonly used in clinical practice for its anti-inflammatory actions. However, little is known about its role in renal ischemia/reperfusion (I/R) injury. In the current study, mice were subjected to I/R injury and HCQ was administered for seven days by gavage prior to surgery. In parallel, HK-2 human renal proximal tubule cells were prophylactically treated with HCQ and then were exposed to hypoxia/reoxygenation (H/R). The results showed that HCQ significantly attenuated renal dysfunction evidenced by blunted decreases in serum creatinine and kidney injury molecular-1 expression and the improvement of HK-2 cell viability. Additionally, HCQ markedly reduced macrophage and neutrophil infiltration, pro-inflammatory cytokine production, and NLRP3 inflammasome activation. Mechanistic studies showed that HCQ could inhibit the priming of the NLRP3 inflammasome by down-regulating I/R or H/R-induced NF-κB signaling. Moreover, HCQ reduced cathepsin (CTS) B, CTSD and CTSL activity, and their redistribution from lysosomes to cytoplasm. CTSB and CTSL (not CTSD) were implicated in I/R triggered NLRP3 inflammasome activation. Notably, we found that HCQ attenuated renal injury through downregulation of CTSB and CTSL-mediated NLRP3 inflammasome activation. This study provides new insights into the anti-inflammatory effect of HCQ in the treatment of AKI.
ArticleNumber 351
Author Wu, Min
Li, Zuo-Lin
Liu, Bi-Cheng
Crowley, Steve D
Tang, Tao-Tao
Lv, Lin-Li
Pan, Ming-Ming
Wang, Feng-Mei
Wen, Yi
Wang, Bin
Author_xml – sequence: 1
  givenname: Tao-Tao
  surname: Tang
  fullname: Tang, Tao-Tao
  organization: Institute of Nephrology, Zhong Da Hospital, Southeast University School of Medicine
– sequence: 2
  givenname: Lin-Li
  surname: Lv
  fullname: Lv, Lin-Li
  email: lvlinli2000@hotmail.com
  organization: Institute of Nephrology, Zhong Da Hospital, Southeast University School of Medicine
– sequence: 3
  givenname: Ming-Ming
  surname: Pan
  fullname: Pan, Ming-Ming
  organization: Institute of Nephrology, Zhong Da Hospital, Southeast University School of Medicine
– sequence: 4
  givenname: Yi
  surname: Wen
  fullname: Wen, Yi
  organization: Institute of Nephrology, Zhong Da Hospital, Southeast University School of Medicine
– sequence: 5
  givenname: Bin
  surname: Wang
  fullname: Wang, Bin
  organization: Institute of Nephrology, Zhong Da Hospital, Southeast University School of Medicine
– sequence: 6
  givenname: Zuo-Lin
  surname: Li
  fullname: Li, Zuo-Lin
  organization: Institute of Nephrology, Zhong Da Hospital, Southeast University School of Medicine
– sequence: 7
  givenname: Min
  surname: Wu
  fullname: Wu, Min
  organization: Institute of Nephrology, Zhong Da Hospital, Southeast University School of Medicine
– sequence: 8
  givenname: Feng-Mei
  surname: Wang
  fullname: Wang, Feng-Mei
  organization: Institute of Nephrology, Zhong Da Hospital, Southeast University School of Medicine
– sequence: 9
  givenname: Steve D
  surname: Crowley
  fullname: Crowley, Steve D
  organization: Division of Nephrology, Department of Medicine, Duke University and Durham VA Medical Centers
– sequence: 10
  givenname: Bi-Cheng
  surname: Liu
  fullname: Liu, Bi-Cheng
  email: liubc64@163.com
  organization: Institute of Nephrology, Zhong Da Hospital, Southeast University School of Medicine
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29500339$$D View this record in MEDLINE/PubMed
BookMark eNp9UkFvFCEYJabG1tof4MVM4sXLWBhgZ7iYmEatyUaN0TP5YL7dZTMDKzBN5-Jvl-22WpsoFyC893h533tKjnzwSMhzRl8zyrvzJJhgqqasqylvu5o_IicNFawWXaeO7p2PyVlKW1oW57SRiyfkuFFyf1Mn5Ofl3MdwPdvNEGL4MTmPFeSMfoKMqYroYahcshscHZxH3GFcTckFXzm_neJcmbmcNs647Py6spA3uEvOVyP2rkj01afl1y-8YFYDjCOkMJYPbHZXkIvKM_J4BUPCs9v9lHx__-7bxWW9_Pzh48XbZW0lX-S6t1T2YAyzCJRxUK3gxqgFCgkcjJALoKLvqeK96Jk0jWgbQbHpQJmutYafkjcH3d1kijOLPkcY9C66EeKsAzj994t3G70OV1p2XEiuisCrW4F9SpiyHksqOAzgMUxJN7QMpW1K3AX68gF0G6ZYcrxBKSGkYl1Bvbjv6LeVu9EUQHsA2BhSirjS1uWb0IpBN2hG9b4H-tADXXqg9z3QvDDZA-ad-P84zYGTCtavMf4x_W_SL043yGg
CitedBy_id crossref_primary_10_3390_biology11030372
crossref_primary_10_52601_bpr_2023_230032
crossref_primary_10_1038_s41419_020_2720_9
crossref_primary_10_1186_s12929_024_01059_w
crossref_primary_10_1096_fj_201903287R
crossref_primary_10_1016_j_scitotenv_2020_142436
crossref_primary_10_1096_fj_202001252R
crossref_primary_10_3390_nu16142290
crossref_primary_10_1111_jcmm_16168
crossref_primary_10_3389_fimmu_2021_645100
crossref_primary_10_1097_CM9_0000000000002377
crossref_primary_10_1007_s12013_024_01242_8
crossref_primary_10_1080_15548627_2025_2483598
crossref_primary_10_3389_fmolb_2022_971219
crossref_primary_10_1016_j_biopha_2020_109913
crossref_primary_10_1016_j_yexcr_2024_114341
crossref_primary_10_2147_DMSO_S373203
crossref_primary_10_1016_j_intimp_2023_110353
crossref_primary_10_1096_fj_202200109RR
crossref_primary_10_1097_SHK_0000000000002339
crossref_primary_10_1159_000542417
crossref_primary_10_1096_fj_202403101R
crossref_primary_10_1016_j_ijpharm_2025_125694
crossref_primary_10_3390_antiox13040489
crossref_primary_10_1177_15353702231214255
crossref_primary_10_2174_1874467215666220822110855
crossref_primary_10_1139_cjpp_2020_0321
crossref_primary_10_3233_JPD_223290
crossref_primary_10_1080_01478885_2020_1826175
crossref_primary_10_1016_j_omtn_2019_06_025
crossref_primary_10_3390_ijms23031546
crossref_primary_10_1155_2020_6428498
crossref_primary_10_1080_01635581_2021_1960388
crossref_primary_10_1007_s11255_021_03017_z
crossref_primary_10_1038_s41598_024_70401_x
crossref_primary_10_1016_j_jksus_2024_103235
crossref_primary_10_1155_2022_2789900
crossref_primary_10_3390_ijms241411304
crossref_primary_10_1513_AnnalsATS_202008_940OC
crossref_primary_10_1007_s10787_025_01841_8
crossref_primary_10_3892_etm_2024_12430
crossref_primary_10_1111_bph_15166
crossref_primary_10_1007_s40620_020_00875_1
crossref_primary_10_3390_antiox12081541
crossref_primary_10_1016_j_abb_2019_02_015
crossref_primary_10_1002_ptr_8527
crossref_primary_10_3389_fimmu_2022_1053754
crossref_primary_10_3390_ijms23105664
crossref_primary_10_3390_ijms22063254
crossref_primary_10_1016_j_trim_2020_101293
crossref_primary_10_1016_j_pharmthera_2020_107587
crossref_primary_10_1016_j_cej_2025_164680
crossref_primary_10_5812_jrps_150336
crossref_primary_10_1016_j_biopha_2020_110848
crossref_primary_10_1097_CM9_0000000000003309
crossref_primary_10_1186_s13075_019_2040_6
crossref_primary_10_1016_j_jconrel_2022_06_049
crossref_primary_10_1016_j_lfs_2025_123608
crossref_primary_10_3389_fendo_2022_907984
crossref_primary_10_2174_0929867329666220906111550
crossref_primary_10_1038_s41398_024_02887_y
crossref_primary_10_3390_cells12060854
crossref_primary_10_1016_j_bbamcr_2021_119190
crossref_primary_10_1093_jpp_rgaf064
crossref_primary_10_3389_fmed_2022_811980
crossref_primary_10_1007_s11010_022_04520_2
crossref_primary_10_3390_nu13113859
crossref_primary_10_1016_j_yjmcc_2019_04_025
crossref_primary_10_1111_jphp_13043
crossref_primary_10_2174_1381612826666200707132920
crossref_primary_10_1038_s41419_024_06731_5
crossref_primary_10_3389_fmolb_2021_671363
crossref_primary_10_1016_j_ejphar_2022_175237
crossref_primary_10_1186_s12974_021_02137_8
crossref_primary_10_31083_j_fbl2807137
crossref_primary_10_1111_ctr_14118
crossref_primary_10_1016_j_biopha_2022_113807
crossref_primary_10_5937_arhfarm72_36150
crossref_primary_10_1002_cbf_3474
crossref_primary_10_1186_s12920_022_01370_1
crossref_primary_10_1016_j_scitotenv_2023_163460
crossref_primary_10_1111_bph_15229
crossref_primary_10_1080_0886022X_2025_2480243
crossref_primary_10_4331_wjbc_v16_i2_107042
crossref_primary_10_1007_s00253_022_11876_4
crossref_primary_10_1371_journal_pone_0294514
crossref_primary_10_1002_iub_1972
crossref_primary_10_1016_j_phymed_2022_154358
crossref_primary_10_1161_CIRCULATIONAHA_118_036771
crossref_primary_10_1007_s12035_024_04105_8
crossref_primary_10_1038_s41420_022_01034_0
crossref_primary_10_1007_s00210_024_03417_9
crossref_primary_10_1016_j_arr_2022_101638
crossref_primary_10_1038_s42003_025_08303_5
crossref_primary_10_1055_a_1798_2003
crossref_primary_10_3389_fimmu_2021_649693
crossref_primary_10_1016_j_trim_2022_101718
crossref_primary_10_3390_ijms232415589
crossref_primary_10_1155_2019_2923072
crossref_primary_10_1007_s11010_025_05359_z
crossref_primary_10_1016_j_jnutbio_2022_109001
crossref_primary_10_3389_fimmu_2025_1535313
crossref_primary_10_3390_antiox11020246
crossref_primary_10_1016_j_imbio_2025_152891
crossref_primary_10_1186_s12985_020_01342_w
crossref_primary_10_1007_s40620_023_01733_6
crossref_primary_10_1016_j_bbrc_2019_11_105
crossref_primary_10_1186_s13287_024_03674_8
crossref_primary_10_3389_fnmol_2022_847440
crossref_primary_10_1016_j_intimp_2023_109697
crossref_primary_10_1681_ASN_2020111561
crossref_primary_10_1097_RHU_0000000000001412
crossref_primary_10_2174_0929867328666210526111318
crossref_primary_10_1097_JS9_0000000000000434
crossref_primary_10_1186_s13075_021_02700_x
crossref_primary_10_1038_s41419_020_2721_8
crossref_primary_10_1016_j_phymed_2022_154021
crossref_primary_10_1139_cjpp_2020_0230
crossref_primary_10_1002_jmri_28784
crossref_primary_10_1177_07482337231224512
crossref_primary_10_3892_mmr_2022_12885
crossref_primary_10_1016_j_jhazmat_2024_133719
crossref_primary_10_3233_CH_200842
crossref_primary_10_1007_s13577_024_01059_w
crossref_primary_10_1016_j_biopha_2018_08_027
crossref_primary_10_1152_ajprenal_00413_2018
crossref_primary_10_1159_000515035
crossref_primary_10_1016_j_micinf_2021_104913
crossref_primary_10_1089_vim_2021_0023
crossref_primary_10_3390_molecules28093817
crossref_primary_10_1186_s12967_020_02283_2
crossref_primary_10_2147_DDDT_S333372
crossref_primary_10_3389_fimmu_2020_02159
crossref_primary_10_1016_j_fsi_2024_109933
crossref_primary_10_1016_j_clim_2020_108461
crossref_primary_10_1016_j_vph_2022_107017
crossref_primary_10_1186_s12967_022_03782_0
crossref_primary_10_3892_ol_2025_14876
crossref_primary_10_3390_ijms21103453
crossref_primary_10_1007_s11940_024_00816_4
crossref_primary_10_1155_2020_8032797
crossref_primary_10_1186_s12974_022_02430_0
crossref_primary_10_2147_IJN_S456533
crossref_primary_10_1007_s00210_020_02034_6
crossref_primary_10_1080_15548627_2020_1848971
crossref_primary_10_3390_ijms26178533
crossref_primary_10_1016_j_jinorgbio_2021_111661
crossref_primary_10_1111_imr_13284
Cites_doi 10.4049/jimmunol.0901363
10.1681/ASN.2015030261
10.1111/j.1600-065X.2011.01043.x
10.1038/ki.2012.261
10.1073/pnas.1319661110
10.1038/ncomms6779
10.1016/S0006-8993(99)01845-4
10.1152/ajprenal.00461.2007
10.1172/JCI45161
10.1111/ajt.12717
10.1016/S1097-2765(02)00599-3
10.1038/ncprheum0292
10.1016/S0232-1513(84)80074-2
10.1038/ki.2012.427
10.1073/pnas.75.7.3327
10.1371/journal.pone.0092673
10.1074/jbc.M301778200
10.1681/ASN.2010020143
10.1371/journal.pone.0143771
10.1152/ajpgi.00316.2004
10.1007/s11010-008-9723-7
10.1038/ki.1991.58
10.1016/j.bbrc.2007.11.104
10.2353/ajpath.2010.090594
10.4049/jimmunol.1500509
10.1093/ndt/gft332
10.1016/j.clim.2006.09.008
10.1016/j.semarthrit.2013.01.001
10.1371/journal.pone.0065913
10.1016/j.cell.2010.01.040
10.1038/ni.1831
10.1097/01.mnh.0000444814.49755.90
10.1073/pnas.0908698106
10.1515/BC.2002.147
10.1016/j.immuni.2013.05.016
10.1681/ASN.2010080798
10.1007/s12016-010-8243-x
10.1038/cddis.2013.225
10.1016/j.bbadis.2014.05.010
10.1124/jpet.113.205732
10.1016/j.bbrc.2015.02.029
10.1073/pnas.79.1.175
10.1038/nm.3893
10.1016/j.ajpath.2014.04.005
10.1038/ni.1631
10.1681/ASN.2016020177
ContentType Journal Article
Copyright The Author(s) 2018
2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: The Author(s) 2018
– notice: 2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88A
88I
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M2P
M7P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
7X8
5PM
DOI 10.1038/s41419-018-0378-3
DatabaseName Springer Nature OA Free Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Biology Database (Alumni Edition)
Science Database (Alumni Edition)
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
Health & Medical Collection (Alumni Edition)
Science Database
Biological Science Database
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Biology Journals (Alumni Edition)
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
ProQuest Central (New)
ProQuest Science Journals (Alumni Edition)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest Science Journals
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList Publicly Available Content Database


CrossRef
MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: PIMPY
  name: Publicly Available Content Database
  url: http://search.proquest.com/publiccontent
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 2041-4889
EndPage 14
ExternalDocumentID PMC5834539
29500339
10_1038_s41419_018_0378_3
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
0R~
3V.
53G
5VS
70F
7X7
88A
88I
8FE
8FH
8FI
8FJ
AAJSJ
ABUWG
ACGFS
ACSMW
ADBBV
ADRAZ
AENEX
AFKRA
AJTQC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
BVXVI
C6C
CCPQU
DIK
DWQXO
E3Z
EBLON
EBS
EJD
EMOBN
FRP
FYUFA
GNUQQ
GROUPED_DOAJ
HCIFZ
HMCUK
HYE
HZ~
IPNFZ
KQ8
LK8
M0L
M2P
M48
M7P
M~E
NAO
O5R
O5S
O9-
OK1
PIMPY
PQQKQ
PROAC
RIG
RNT
RPM
SNYQT
TR2
UKHRP
W2D
AASML
AAYXX
AFFHD
CITATION
PHGZM
PHGZT
PQGLB
CGR
CUY
CVF
ECM
EIF
NPM
7XB
8FK
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
PRINS
Q9U
7X8
5PM
ID FETCH-LOGICAL-c536t-dc05dabb1cea013a9743bb96e45a3ab456a04dd093d4d15b247240e28a9b87cb3
IEDL.DBID BENPR
ISICitedReferencesCount 168
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000427423300003&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 2041-4889
IngestDate Tue Nov 04 01:56:54 EST 2025
Sun Nov 09 13:40:28 EST 2025
Sat Nov 29 15:03:10 EST 2025
Thu Apr 03 06:57:43 EDT 2025
Sat Nov 29 05:56:56 EST 2025
Tue Nov 18 22:00:44 EST 2025
Fri Feb 21 02:37:06 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Language English
License Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c536t-dc05dabb1cea013a9743bb96e45a3ab456a04dd093d4d15b247240e28a9b87cb3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://www.proquest.com/docview/2019445918?pq-origsite=%requestingapplication%
PMID 29500339
PQID 2019445918
PQPubID 2041963
PageCount 14
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_5834539
proquest_miscellaneous_2010372889
proquest_journals_2019445918
pubmed_primary_29500339
crossref_citationtrail_10_1038_s41419_018_0378_3
crossref_primary_10_1038_s41419_018_0378_3
springer_journals_10_1038_s41419_018_0378_3
PublicationCentury 2000
PublicationDate 2018-03-02
PublicationDateYYYYMMDD 2018-03-02
PublicationDate_xml – month: 03
  year: 2018
  text: 2018-03-02
  day: 02
PublicationDecade 2010
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle Cell death & disease
PublicationTitleAbbrev Cell Death Dis
PublicationTitleAlternate Cell Death Dis
PublicationYear 2018
Publisher Nature Publishing Group UK
Springer Nature B.V
Publisher_xml – name: Nature Publishing Group UK
– name: Springer Nature B.V
References Olsen, Schleich, Karp (CR5) 2013; 43
Bauernfeind (CR37) 2009; 183
Martinon, Burns, Tschopp (CR15) 2002; 10
Guo, Callaway, Ting (CR28) 2015; 21
Thurman (CR4) 2007; 123
Weinberg (CR41) 1991; 39
Lorenz, Darisipudi, Anders (CR23) 2014; 29
Kim (CR26) 2013; 346
Thomé (CR10) 2013; 8
Decuypere, Pirenne, Jochmans (CR44) 2014; 14
Bakker (CR27) 2014; 184
Boaru (CR38) 2015; 458
Todorovic (CR12) 2014; 9
Fang, Liu, Dahmen, Dirsch (CR13) 2013; 4
Orlowski (CR33) 2015; 195
Wattiaux, Wattiaux-De Coninck (CR40) 1984; 26
Montaser, Lalmanach, Mach (CR34) 2002; 383
Jiang, Liu, Luo, Dong (CR43) 2010; 176
Ma, Wang, Chen, Cao (CR45) 2015; 1852
Iyer (CR25) 2009; 106
Chang, Ko, Clark (CR22) 2014; 23
Sperber (CR9) 1993; 20
Anders, Muruve (CR21) 2011; 22
Anders (CR36) 2016; 27
Vilaysane (CR24) 2010; 21
Kyburz, Brentano, Gay (CR11) 2006; 2
Li, Burdmann, Mehta (CR1) 2013; 83
Rabb (CR2) 2016; 27
Anagli (CR30) 2008; 366
Barrett (CR39) 1980; 39
Jiang (CR42) 2012; 82
Bourke (CR14) 2015; 10
Park (CR48) 2003; 278
Ziegler, Unanue (CR8) 1982; 79
Bonventre, Yang (CR3) 2011; 121
Muñoz-Planillo (CR19) 2013; 38
Ben-Zvi, Kivity, Langevitz, Shoenfeld (CR6) 2012; 42
Tiwari (CR31) 2008; 312
Ohkuma, Poole (CR7) 1978; 75
Baskin-Bey (CR29) 2005; 288
Leemans, Cassel, Sutterwala (CR17) 2011; 243
Yasuda (CR35) 2008; 294
Schroder, Tschopp (CR16) 2010; 140
Hornung (CR20) 2008; 9
Kanayama (CR47) 2015; 6
Işlekel, Işlekel, Güner, Ozdamar (CR32) 2015; 843
Liu (CR46) 2013; 110
Zhou, Tardivel, Thorens, Choi, Tschopp (CR18) 2010; 11
H Guo (378_CR28) 2015; 21
JV Bonventre (378_CR3) 2011; 121
SG Boaru (378_CR38) 2015; 458
JP Decuypere (378_CR44) 2014; 14
F Martinon (378_CR15) 2002; 10
V Hornung (378_CR20) 2008; 9
PK Li (378_CR1) 2013; 83
D Kyburz (378_CR11) 2006; 2
KM Park (378_CR48) 2003; 278
H Işlekel (378_CR32) 2015; 843
PJ Bakker (378_CR27) 2014; 184
K Sperber (378_CR9) 1993; 20
HK Ziegler (378_CR8) 1982; 79
FG Bauernfeind (378_CR37) 2009; 183
I Ben-Zvi (378_CR6) 2012; 42
M Jiang (378_CR42) 2012; 82
ES Baskin-Bey (378_CR29) 2005; 288
H Rabb (378_CR2) 2016; 27
G Lorenz (378_CR23) 2014; 29
R Zhou (378_CR18) 2010; 11
H Yasuda (378_CR35) 2008; 294
J Anagli (378_CR30) 2008; 366
H Fang (378_CR13) 2013; 4
R Wattiaux (378_CR40) 1984; 26
Z Todorovic (378_CR12) 2014; 9
HJ Anders (378_CR36) 2016; 27
JM Thurman (378_CR4) 2007; 123
R Muñoz-Planillo (378_CR19) 2013; 38
Y Liu (378_CR46) 2013; 110
HJ Anders (378_CR21) 2011; 22
A Chang (378_CR22) 2014; 23
M Kanayama (378_CR47) 2015; 6
JC Leemans (378_CR17) 2011; 243
K Schroder (378_CR16) 2010; 140
M Montaser (378_CR34) 2002; 383
M Tiwari (378_CR31) 2008; 312
AJ Barrett (378_CR39) 1980; 39
NJ Olsen (378_CR5) 2013; 43
HJ Kim (378_CR26) 2013; 346
S Ma (378_CR45) 2015; 1852
JM Weinberg (378_CR41) 1991; 39
M Jiang (378_CR43) 2010; 176
GM Orlowski (378_CR33) 2015; 195
S Ohkuma (378_CR7) 1978; 75
L Bourke (378_CR14) 2015; 10
R Thomé (378_CR10) 2013; 8
A Vilaysane (378_CR24) 2010; 21
SS Iyer (378_CR25) 2009; 106
References_xml – volume: 183
  start-page: 787
  year: 2009
  end-page: 791
  ident: CR37
  article-title: Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.0901363
– volume: 27
  start-page: 371
  year: 2016
  end-page: 379
  ident: CR2
  article-title: Inflammation in AKI: Current Understanding, Key Questions, and Knowledge Gaps
  publication-title: J. Am. Soc. Nephrol.
  doi: 10.1681/ASN.2015030261
– volume: 39
  start-page: 9
  year: 1980
  end-page: 14
  ident: CR39
  article-title: The many forms and functions of cellular proteinases
  publication-title: Fed. Proc.
– volume: 243
  start-page: 152
  year: 2011
  end-page: 162
  ident: CR17
  article-title: Sensing damage by the NLRP3 inflammasome
  publication-title: Immunol. Rev.
  doi: 10.1111/j.1600-065X.2011.01043.x
– volume: 82
  start-page: 1271
  year: 2012
  end-page: 1283
  ident: CR42
  article-title: Autophagy in proximal tubules protects against acute kidney injury
  publication-title: Kidney Int.
  doi: 10.1038/ki.2012.261
– volume: 110
  start-page: 20364
  year: 2013
  end-page: 20371
  ident: CR46
  article-title: Autosis is a Na+,K+-ATPase-regulated form of cell death triggered by autophagy-inducing peptides, starvation, and hypoxia-ischemia
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.1319661110
– volume: 6
  year: 2015
  ident: CR47
  article-title: Autophagy enhances NFκB activity in specific tissue macrophages by sequestering A20 to boost antifungal immunity
  publication-title: Nat. Commun.
  doi: 10.1038/ncomms6779
– volume: 843
  start-page: 18
  year: 2015
  end-page: 24
  ident: CR32
  article-title: Evaluation of lipid peroxidation, cathepsin L and acid phosphatase activities in experimental brainischemia-reperfusion
  publication-title: Brain. Res.
  doi: 10.1016/S0006-8993(99)01845-4
– volume: 294
  start-page: F1050
  year: 2008
  end-page: F1058
  ident: CR35
  article-title: Chloroquine and inhibition of Toll-like receptor 9 protect from sepsis-induced acute kidney injury
  publication-title: Am. J. Physiol. Ren. Physiol.
  doi: 10.1152/ajprenal.00461.2007
– volume: 121
  start-page: 4210
  year: 2011
  end-page: 4221
  ident: CR3
  article-title: Cellular pathophysiology of ischemic acute kidney injury
  publication-title: J. Clin. Invest.
  doi: 10.1172/JCI45161
– volume: 14
  start-page: 1464
  year: 2014
  end-page: 1465
  ident: CR44
  article-title: Autophagy in renal ischemia-reperfusion injury: friend or foe?
  publication-title: Am. J. Transplant.
  doi: 10.1111/ajt.12717
– volume: 10
  start-page: 417
  year: 2002
  end-page: 426
  ident: CR15
  article-title: The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta
  publication-title: Mol. Cell.
  doi: 10.1016/S1097-2765(02)00599-3
– volume: 2
  start-page: 458
  year: 2006
  end-page: 459
  ident: CR11
  article-title: Mode of action of hydroxychloroquine in RA-evidence of an inhibitory effect on toll-like receptor signaling
  publication-title: Nat. Clin. Pract. Rheumatol.
  doi: 10.1038/ncprheum0292
– volume: 26
  start-page: 85
  year: 1984
  end-page: 106
  ident: CR40
  article-title: Effects of ischemia on lysosomes
  publication-title: Int. Rev. Exp. Pathol.
  doi: 10.1016/S0232-1513(84)80074-2
– volume: 83
  start-page: 372
  year: 2013
  end-page: 376
  ident: CR1
  article-title: Acute kidney injury: global health alert
  publication-title: Kidney Int.
  doi: 10.1038/ki.2012.427
– volume: 75
  start-page: 3327
  year: 1978
  end-page: 3331
  ident: CR7
  article-title: Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.75.7.3327
– volume: 9
  start-page: e92673
  year: 2014
  ident: CR12
  article-title: Acute pretreatment with chloroquine attenuates renal I/R injury in rats
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0092673
– volume: 278
  start-page: 27256
  year: 2003
  end-page: 27266
  ident: CR48
  article-title: Inducible nitric-oxide synthase is an important contributor to prolonged protective effects of ischemic preconditioning in the mouse kidney
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M301778200
– volume: 21
  start-page: 1732
  year: 2010
  end-page: 1744
  ident: CR24
  article-title: The NLRP3 inflammasome promotes renal inflammation and contributes to CKD
  publication-title: J. Am. Soc. Nephrol.
  doi: 10.1681/ASN.2010020143
– volume: 10
  start-page: e0143771
  year: 2015
  ident: CR14
  article-title: Hydroxychloroquine Protects against Cardiac Ischaemia/Reperfusion Injury In Vivo via Enhancement of ERK1/2 Phosphorylation
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0143771
– volume: 288
  start-page: G396
  year: 2005
  end-page: G402
  ident: CR29
  article-title: Cathepsin B inactivation attenuates hepatocyte apoptosis and liver damage in steatotic livers after cold ischemia-warm reperfusion injury
  publication-title: Am. J. Physiol. Gastrointest. Liver. Physiol.
  doi: 10.1152/ajpgi.00316.2004
– volume: 312
  start-page: 81
  year: 2008
  end-page: 91
  ident: CR31
  article-title: Myocardial ischemia and reperfusion injury in rats: lysosomal hydrolases and matrix metalloproteinases mediated cellular damage
  publication-title: Mol. Cell. Biochem.
  doi: 10.1007/s11010-008-9723-7
– volume: 39
  start-page: 476
  year: 1991
  end-page: 500
  ident: CR41
  article-title: The cell biology of ischemic renal injury
  publication-title: Kidney Int.
  doi: 10.1038/ki.1991.58
– volume: 366
  start-page: 86
  year: 2008
  end-page: 91
  ident: CR30
  article-title: Effects of cathepsins B and L inhibition on postischemic protein alterations in the brain
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/j.bbrc.2007.11.104
– volume: 176
  start-page: 1181
  year: 2010
  end-page: 1192
  ident: CR43
  article-title: Autophagy is a renoprotective mechanism during in vitro hypoxia and in vivo ischemia-reperfusion injury
  publication-title: Am. J. Pathol.
  doi: 10.2353/ajpath.2010.090594
– volume: 195
  start-page: 1685
  year: 2015
  end-page: 1697
  ident: CR33
  article-title: Multiple cathepsins promote Pro-IL-1β synthesis and NLRP3-Mediated IL-1β activation
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.1500509
– volume: 29
  start-page: 41
  year: 2014
  end-page: 48
  ident: CR23
  article-title: Canonical and non-canonical effects of the NLRP3 inflammasome in kidney inflammation and fibrosis
  publication-title: Nephrol. Dial. Transplant.
  doi: 10.1093/ndt/gft332
– volume: 123
  start-page: 7
  year: 2007
  end-page: 13
  ident: CR4
  article-title: Triggers of inflammation after renal ischemia/reperfusion
  publication-title: Clin. Immunol.
  doi: 10.1016/j.clim.2006.09.008
– volume: 43
  start-page: 264
  year: 2013
  end-page: 272
  ident: CR5
  article-title: Multifaceted effects of hydroxychloroquine in human disease
  publication-title: Semin. Arthritis Rheum.
  doi: 10.1016/j.semarthrit.2013.01.001
– volume: 27
  start-page: 2564
  year: 2016
  end-page: 2575
  ident: CR36
  article-title: Of inflammasomes and alarmins: IL-1β and IL-1α in kidney disease
  publication-title: J. Am. Soc. Nephrol.
– volume: 8
  start-page: e65913
  year: 2013
  ident: CR10
  article-title: Chloroquine treatment enhances regulatory T cells and reduces the severity of experimental autoimmune encephalomyelitis
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0065913
– volume: 140
  start-page: 821
  year: 2010
  end-page: 832
  ident: CR16
  article-title: The inflammasomes
  publication-title: Cell
  doi: 10.1016/j.cell.2010.01.040
– volume: 11
  start-page: 136
  year: 2010
  end-page: 140
  ident: CR18
  article-title: Thioredoxin-interacting protein links oxidative stress to inflammasome activation
  publication-title: Nat. Immunol.
  doi: 10.1038/ni.1831
– volume: 23
  start-page: 204
  year: 2014
  end-page: 210
  ident: CR22
  article-title: The emerging role of the inflammasome in kidney diseases
  publication-title: Curr. Opin. Nephrol. Hypertens.
  doi: 10.1097/01.mnh.0000444814.49755.90
– volume: 106
  start-page: 20388
  year: 2009
  end-page: 20393
  ident: CR25
  article-title: Necrotic cells trigger a sterile inflammatory response through the Nlrp3 inflammasome
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.0908698106
– volume: 383
  start-page: 1305
  year: 2002
  end-page: 1308
  ident: CR34
  article-title: CA-074, but not its methyl ester CA-074Me, is a selective inhibitor of cathepsin B within living cells
  publication-title: Biol. Chem.
  doi: 10.1515/BC.2002.147
– volume: 38
  start-page: 1142
  year: 2013
  end-page: 1153
  ident: CR19
  article-title: K efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter
  publication-title: Immunity
  doi: 10.1016/j.immuni.2013.05.016
– volume: 22
  start-page: 1007
  year: 2011
  end-page: 1018
  ident: CR21
  article-title: The inflammasomes in kidney disease
  publication-title: J. Am. Soc. Nephrol.
  doi: 10.1681/ASN.2010080798
– volume: 42
  start-page: 145
  year: 2012
  end-page: 153
  ident: CR6
  article-title: Hydroxychloroquine: from malaria to autoimmunity
  publication-title: Clin. Rev. Allergy Immunol.
  doi: 10.1007/s12016-010-8243-x
– volume: 4
  year: 2013
  ident: CR13
  article-title: Dual role of chloroquine in liver ischemia reperfusion injury: reduction of liver damage in early phase, but aggravation in late phase
  publication-title: Cell Death Dis.
  doi: 10.1038/cddis.2013.225
– volume: 1852
  start-page: 271
  year: 2015
  end-page: 276
  ident: CR45
  article-title: The role of the autophagy in myocardial ischemia/reperfusion injury
  publication-title: Biochim. Biophys. Acta
  doi: 10.1016/j.bbadis.2014.05.010
– volume: 346
  start-page: 465
  year: 2013
  end-page: 472
  ident: CR26
  article-title: NLRP3 inflammasome knockout mice are protected against ischemic but not cisplatin-induced acute kidney injury
  publication-title: J. Pharmacol. Exp. Ther.
  doi: 10.1124/jpet.113.205732
– volume: 458
  start-page: 700
  year: 2015
  end-page: 706
  ident: CR38
  article-title: NLRP3 inflammasome expression is driven by NF-κB in cultured hepatocytes
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/j.bbrc.2015.02.029
– volume: 79
  start-page: 175
  year: 1982
  end-page: 178
  ident: CR8
  article-title: Decrease in macrophage antigen catabolism caused by ammonia and chloroquine is associated with inhibition of antigen presentation to T cells
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.79.1.175
– volume: 20
  start-page: 803
  year: 1993
  end-page: 808
  ident: CR9
  article-title: Selective regulation of cytokine secretion by hydroxychloroquine: inhibition of interleukin 1 alpha (IL-1-alpha) and IL-6 in human monocytes and T cells
  publication-title: J. Rheumatol.
– volume: 21
  start-page: 677
  year: 2015
  end-page: 687
  ident: CR28
  article-title: Inflammasomes: mechanism of action, role in disease, and therapeutics
  publication-title: Nat. Med.
  doi: 10.1038/nm.3893
– volume: 184
  start-page: 2013
  year: 2014
  end-page: 2022
  ident: CR27
  article-title: A tissue-specific role for Nlrp3 in tubular epithelial repair after renal ischemia/reperfusion
  publication-title: Am. J. Pathol.
  doi: 10.1016/j.ajpath.2014.04.005
– volume: 9
  start-page: 847
  year: 2008
  end-page: 856
  ident: CR20
  article-title: Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization
  publication-title: Nat. Immunol.
  doi: 10.1038/ni.1631
– volume: 10
  start-page: 417
  year: 2002
  ident: 378_CR15
  publication-title: Mol. Cell.
  doi: 10.1016/S1097-2765(02)00599-3
– volume: 195
  start-page: 1685
  year: 2015
  ident: 378_CR33
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.1500509
– volume: 243
  start-page: 152
  year: 2011
  ident: 378_CR17
  publication-title: Immunol. Rev.
  doi: 10.1111/j.1600-065X.2011.01043.x
– volume: 27
  start-page: 2564
  year: 2016
  ident: 378_CR36
  publication-title: J. Am. Soc. Nephrol.
  doi: 10.1681/ASN.2016020177
– volume: 82
  start-page: 1271
  year: 2012
  ident: 378_CR42
  publication-title: Kidney Int.
  doi: 10.1038/ki.2012.261
– volume: 11
  start-page: 136
  year: 2010
  ident: 378_CR18
  publication-title: Nat. Immunol.
  doi: 10.1038/ni.1831
– volume: 4
  year: 2013
  ident: 378_CR13
  publication-title: Cell Death Dis.
  doi: 10.1038/cddis.2013.225
– volume: 83
  start-page: 372
  year: 2013
  ident: 378_CR1
  publication-title: Kidney Int.
  doi: 10.1038/ki.2012.427
– volume: 75
  start-page: 3327
  year: 1978
  ident: 378_CR7
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.75.7.3327
– volume: 183
  start-page: 787
  year: 2009
  ident: 378_CR37
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.0901363
– volume: 39
  start-page: 476
  year: 1991
  ident: 378_CR41
  publication-title: Kidney Int.
  doi: 10.1038/ki.1991.58
– volume: 6
  year: 2015
  ident: 378_CR47
  publication-title: Nat. Commun.
  doi: 10.1038/ncomms6779
– volume: 312
  start-page: 81
  year: 2008
  ident: 378_CR31
  publication-title: Mol. Cell. Biochem.
  doi: 10.1007/s11010-008-9723-7
– volume: 9
  start-page: e92673
  year: 2014
  ident: 378_CR12
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0092673
– volume: 21
  start-page: 677
  year: 2015
  ident: 378_CR28
  publication-title: Nat. Med.
  doi: 10.1038/nm.3893
– volume: 366
  start-page: 86
  year: 2008
  ident: 378_CR30
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/j.bbrc.2007.11.104
– volume: 458
  start-page: 700
  year: 2015
  ident: 378_CR38
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/j.bbrc.2015.02.029
– volume: 1852
  start-page: 271
  year: 2015
  ident: 378_CR45
  publication-title: Biochim. Biophys. Acta
  doi: 10.1016/j.bbadis.2014.05.010
– volume: 20
  start-page: 803
  year: 1993
  ident: 378_CR9
  publication-title: J. Rheumatol.
– volume: 346
  start-page: 465
  year: 2013
  ident: 378_CR26
  publication-title: J. Pharmacol. Exp. Ther.
  doi: 10.1124/jpet.113.205732
– volume: 22
  start-page: 1007
  year: 2011
  ident: 378_CR21
  publication-title: J. Am. Soc. Nephrol.
  doi: 10.1681/ASN.2010080798
– volume: 39
  start-page: 9
  year: 1980
  ident: 378_CR39
  publication-title: Fed. Proc.
– volume: 29
  start-page: 41
  year: 2014
  ident: 378_CR23
  publication-title: Nephrol. Dial. Transplant.
  doi: 10.1093/ndt/gft332
– volume: 10
  start-page: e0143771
  year: 2015
  ident: 378_CR14
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0143771
– volume: 21
  start-page: 1732
  year: 2010
  ident: 378_CR24
  publication-title: J. Am. Soc. Nephrol.
  doi: 10.1681/ASN.2010020143
– volume: 140
  start-page: 821
  year: 2010
  ident: 378_CR16
  publication-title: Cell
  doi: 10.1016/j.cell.2010.01.040
– volume: 176
  start-page: 1181
  year: 2010
  ident: 378_CR43
  publication-title: Am. J. Pathol.
  doi: 10.2353/ajpath.2010.090594
– volume: 43
  start-page: 264
  year: 2013
  ident: 378_CR5
  publication-title: Semin. Arthritis Rheum.
  doi: 10.1016/j.semarthrit.2013.01.001
– volume: 110
  start-page: 20364
  year: 2013
  ident: 378_CR46
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.1319661110
– volume: 79
  start-page: 175
  year: 1982
  ident: 378_CR8
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.79.1.175
– volume: 288
  start-page: G396
  year: 2005
  ident: 378_CR29
  publication-title: Am. J. Physiol. Gastrointest. Liver. Physiol.
  doi: 10.1152/ajpgi.00316.2004
– volume: 843
  start-page: 18
  year: 2015
  ident: 378_CR32
  publication-title: Brain. Res.
  doi: 10.1016/S0006-8993(99)01845-4
– volume: 278
  start-page: 27256
  year: 2003
  ident: 378_CR48
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M301778200
– volume: 38
  start-page: 1142
  year: 2013
  ident: 378_CR19
  publication-title: Immunity
  doi: 10.1016/j.immuni.2013.05.016
– volume: 23
  start-page: 204
  year: 2014
  ident: 378_CR22
  publication-title: Curr. Opin. Nephrol. Hypertens.
  doi: 10.1097/01.mnh.0000444814.49755.90
– volume: 383
  start-page: 1305
  year: 2002
  ident: 378_CR34
  publication-title: Biol. Chem.
  doi: 10.1515/BC.2002.147
– volume: 26
  start-page: 85
  year: 1984
  ident: 378_CR40
  publication-title: Int. Rev. Exp. Pathol.
  doi: 10.1016/S0232-1513(84)80074-2
– volume: 294
  start-page: F1050
  year: 2008
  ident: 378_CR35
  publication-title: Am. J. Physiol. Ren. Physiol.
  doi: 10.1152/ajprenal.00461.2007
– volume: 27
  start-page: 371
  year: 2016
  ident: 378_CR2
  publication-title: J. Am. Soc. Nephrol.
  doi: 10.1681/ASN.2015030261
– volume: 123
  start-page: 7
  year: 2007
  ident: 378_CR4
  publication-title: Clin. Immunol.
  doi: 10.1016/j.clim.2006.09.008
– volume: 42
  start-page: 145
  year: 2012
  ident: 378_CR6
  publication-title: Clin. Rev. Allergy Immunol.
  doi: 10.1007/s12016-010-8243-x
– volume: 14
  start-page: 1464
  year: 2014
  ident: 378_CR44
  publication-title: Am. J. Transplant.
  doi: 10.1111/ajt.12717
– volume: 121
  start-page: 4210
  year: 2011
  ident: 378_CR3
  publication-title: J. Clin. Invest.
  doi: 10.1172/JCI45161
– volume: 106
  start-page: 20388
  year: 2009
  ident: 378_CR25
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.0908698106
– volume: 8
  start-page: e65913
  year: 2013
  ident: 378_CR10
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0065913
– volume: 184
  start-page: 2013
  year: 2014
  ident: 378_CR27
  publication-title: Am. J. Pathol.
  doi: 10.1016/j.ajpath.2014.04.005
– volume: 9
  start-page: 847
  year: 2008
  ident: 378_CR20
  publication-title: Nat. Immunol.
  doi: 10.1038/ni.1631
– volume: 2
  start-page: 458
  year: 2006
  ident: 378_CR11
  publication-title: Nat. Clin. Pract. Rheumatol.
  doi: 10.1038/ncprheum0292
SSID ssj0000330256
Score 2.5569913
Snippet Inflammation is a major contributor to the pathogenesis of ischemic acute kidney injury (AKI), which complicates the post-operative outcomes of large numbers...
SourceID pubmedcentral
proquest
pubmed
crossref
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 351
SubjectTerms 13/21
13/51
13/89
14
14/19
38
38/77
64/60
82/80
Acute Kidney Injury - drug therapy
Animals
Anti-Inflammatory Agents - metabolism
Anti-Inflammatory Agents - therapeutic use
Antibodies
Biochemistry
Biomedical and Life Sciences
Cathepsin B - metabolism
Cathepsin L
Cathepsin L - metabolism
Cell activation
Cell Biology
Cell Culture
Cell Line
Cell Survival - drug effects
Creatinine
Creatinine - blood
Cytoplasm
Disease Models, Animal
Hepatitis A Virus Cellular Receptor 1 - blood
Humans
Hydroxychloroquine
Hydroxychloroquine - metabolism
Hydroxychloroquine - therapeutic use
Hypoxia
Immunology
Inflammasomes
Inflammasomes - metabolism
Inflammation
Ischemia
Kidneys
Life Sciences
Lysosomes
Macrophages
Macrophages - drug effects
Male
Mice
Mice, Inbred C57BL
Neutrophil Infiltration - drug effects
NF-kappa B - metabolism
NF-κB protein
NLR Family, Pyrin Domain-Containing 3 Protein - metabolism
Renal function
Reperfusion
Reperfusion Injury - drug therapy
Rodents
Surgery
Title Hydroxychloroquine attenuates renal ischemia/reperfusion injury by inhibiting cathepsin mediated NLRP3 inflammasome activation
URI https://link.springer.com/article/10.1038/s41419-018-0378-3
https://www.ncbi.nlm.nih.gov/pubmed/29500339
https://www.proquest.com/docview/2019445918
https://www.proquest.com/docview/2010372889
https://pubmed.ncbi.nlm.nih.gov/PMC5834539
Volume 9
WOSCitedRecordID wos000427423300003&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: DOAJ Open Access Full Text
  customDbUrl:
  eissn: 2041-4889
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000330256
  issn: 2041-4889
  databaseCode: DOA
  dateStart: 20100101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 2041-4889
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000330256
  issn: 2041-4889
  databaseCode: M~E
  dateStart: 20100101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
– providerCode: PRVPQU
  databaseName: Biological Science Database
  customDbUrl:
  eissn: 2041-4889
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000330256
  issn: 2041-4889
  databaseCode: M7P
  dateStart: 20100101
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/biologicalscijournals
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 2041-4889
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000330256
  issn: 2041-4889
  databaseCode: BENPR
  dateStart: 20100101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Health & Medical Collection
  customDbUrl:
  eissn: 2041-4889
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000330256
  issn: 2041-4889
  databaseCode: 7X7
  dateStart: 20100101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Publicly Available Content Database
  customDbUrl:
  eissn: 2041-4889
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000330256
  issn: 2041-4889
  databaseCode: PIMPY
  dateStart: 20100101
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/publiccontent
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Science Database (subscription)
  customDbUrl:
  eissn: 2041-4889
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000330256
  issn: 2041-4889
  databaseCode: M2P
  dateStart: 20100101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/sciencejournals
  providerName: ProQuest
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpR1di9QwMHi7Cr74_bF6LhV8Uoptk7TJk6jccYK3lENhfSr5Kltxu-t2V9gXf7sz6cexHt6LL0Mhk6RhJsl8ZYaQVxF13CVZGboUAEutDpViUSg1l1JZoahivthENpuJ-VzmncGt6cIq-zPRH9R2ZdBGDko6qNuMy1i8W_8MsWoUele7EhpHZIyZytiIjD-czPKLwcoSgboOl3rvzqTibcNihu92YnxZhqEBhxfSFSnzarDkXx5TfxGd3v3fJdwjdzoRNHjf8sx9csPVD8ittijl_iH5fba3GNtiFqDKw_gghgaYhLPeoVgabBx2rkApdssK00ut3abcoc0tqOrvQKFA7-FrUekKI6oDnxd23VR14B-pgIAbzD5f5BRwSuDGpWpWS5jA9GXWHpGvpydfPp6FXZWG0HCabkNrIm6V1rFxCuRJBQoK1VqmjnEgtAYBTUXM2khSy2zMdcIykCJcIpTUIjOaPiajelW7pyRIXZoI0KmMzBxTrpQRMyk6ClHro7yckKgnVWG6FOZYSeNH4V3pVBQtdQugboHULeiEvB66rNv8HdchH_eEK7qt3BSXVJuQl0MzbEL0rKjarXYeB0ZIhJAT8qRll2G2RHJkQ2jJDhhpQMAE34ctdbXwib65oIxjzzc9y13-1j8X8ez6RTwnt5OW-cMoOSaj7WbnXpCb5te2ajZTcpTNMw_FtNtLU2-mAHie5AgzgOP803n-7Q8vJi0b
linkProvider ProQuest
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9NAEF6VAioX3o9AASPBBWRh78PePSCEgCpVQ1ShIuXm7iuKq8YOcQLKhZ_Eb2TGjl2Fit564GJZ2l171_529pud2RlCXkbMC0_TcegTuPDEmVBrHoXKCKW0k5ppXiebSIdDORqpwy3yuz0Lg26VrUysBbUrLe6Rg5IO6jYXKpbvZ99DzBqF1tU2hUYDiwO_-gkqW_Vu_xP831eU7n0--tgP11kFQitYsgidjYTTxsTWa-A_Ggg1M0YlngvomAFCoSPuHGj6jrtYGMpTWPU8lVoZmVrD4LlXyFWQ4ym6kKWjtNvTiRhDCtEaT5l8W_GY4ymhGM-xoSPC5vJ3jtOed838yz5bL3t7t_63D3ab3FwT7OBDMyPukC1f3CXXm5Sbq3vkV3_l0HPHTk5LHA-Q7ABDjBZLJN3B3GPjHFR-P80xeNbMz8dL3FEM8uIE8BeYFdxNcpOjv3hQR72dVXkR1EdwgL4Hw8HXQwZ1xjDXproqp_AC2yaRu0--XcrgH5Dtoiz8IxIkPqESNEarUs-1H6uI2wTNoKjTMjHukaiFRmbXAdoxT8hpVjsKMJk1aMoATRmiKWM98rprMmuik1xUebcFSrYWVFV2hpIeedEVg4hBu5EufLms68ATqJSqRx428OzeRpVA2ENJugHcrgKGL98sKfJJHcZcSMYFtnzTQvysW_8cxOOLB_Gc7PSPvgyywf7w4Am5QZuJF0Z0l2wv5kv_lFyzPxZ5NX9Wz9yAHF828v8AguCDSg
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwELZKeYgLb8pCASPBBRQ160diHxBClFWrltUKgdRbsB1HG9Qm280uaC_8MH4dM3lVS0VvPXCJItlO7OQb-xvPeIaQlyH30rM4C3wEFxGlNjBGhIG2UmuTKsONqJNNxOOxOjrSkw3yuzsLg26V3ZxYT9Rp6XCPHJR0ULeF1EO1k7VuEZPd0bvZaYAZpNDS2qXTaCBy4Fc_QX2r3u7vwr9-xdjo45cPe0GbYSBwkkeLIHWhTI21Q-cNcCED5JpbqyMvJHTSArkwoUhT0PpTkQ6lZSKGFdAzZbRVsbMcnnuFXI2FlChdn9ik398JOUc60RlSudqpxFDgiaEhnmlDp4T1pfAcvz3vpvmXrbZeAke3_-ePd4fcaok3fd9Iyl2y4Yt75HqTinN1n_zaW6Xo0eOmxyWODcg3xdCjxRLJOJ17bJxXDuMrYFCtmZ9nS9xppHnxHXBJ7QruprnN0Y-c1tFwZ1Ve0PpoDtB6Oj78POFQJwMZPDFVeQIvcF1yuQfk66UM_iHZLMrCPyI08hFToEk6HXthfKZD4SI0j6Kuy2U2IGEHk8S1gdsxf8hxUjsQcJU0yEoAWQkiK-ED8rpvMmuillxUebsDTdJOYFVyhpgBedEXw9SD9iRT-HJZ14EnMKX0gGw1UO3fxrREEYCSeA3EfQUMa75eUuTTOry5VFxIbPmmg_tZt_45iMcXD-I5uQGATw73xwdPyE3WyGAQsm2yuZgv_VNyzf1Y5NX8WS3ElHy7bOD_AUpqjBc
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Hydroxychloroquine+attenuates+renal+ischemia%2Freperfusion+injury+by+inhibiting+cathepsin+mediated+NLRP3+inflammasome+activation&rft.jtitle=Cell+death+%26+disease&rft.au=Tao-Tao%2C+Tang&rft.au=Lin-Li%2C+Lv&rft.au=Ming-Ming+Pan&rft.au=Wen%2C+Yi&rft.date=2018-03-02&rft.pub=Springer+Nature+B.V&rft.eissn=2041-4889&rft.volume=9&rft.spage=1&rft.epage=14&rft_id=info:doi/10.1038%2Fs41419-018-0378-3&rft.externalDBID=HAS_PDF_LINK
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2041-4889&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2041-4889&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2041-4889&client=summon